23andMe, the once revered pioneer in the personal DNA testing market, has dropped a bombshell on its employees with the notice of possible large-scale layoffs amidst ongoing bankruptcy proceedings. The San Francisco-based company, grappling with financial issues, has warned approximately 250 workers, including remote employees, about its unstable future. A document filed with California's Employment Development Department, known as the WARN notice, indicated that much of its workforce could face unemployment by the end of June if a favorable acquisition doesn't come through to save the business and their jobs.
According to the San Francisco Chronicle, the closure of the San Francisco office at 870 Market Street comes on the heels of 23andMe's insolvency woes. Caught in a maelstrom of Chapter 11 bankruptcy, the company, famous for at-home genetic testing, pointed to the need to downsize its real estate presence amid fiscal tightening. The severity of the situation was underscored by a brazen cyberattack the year prior, exposing millions of users' sensitive data, and the company's value plummeting from a once staggering $6 billion benchmark.
Furthermore, the SFGATE report added to the decline narrative, mapping out the potential layoff of key personnel. Executives such as the CEO, CFO, chief security officer, and a cadre of scientists and engineers all find their futures in uncertainty. The WARN document outlined a stark rendering of the company's present turmoil, with June 17 earmarked as a critical date for the company to seek bankruptcy court approval for a sale.
The filing with California officials suggests the company is actively contemplating varied outcomes, including an acquisition as a whole or in parts, or even the possibility of failing to secure a buyer. Employees were notified of the potential workforce reduction "at least 60 days" before the possible separation date, a move that aligns with the company's previously stated commitment to its staff, despite facing dire straits. Additionally, amidst the public's uproar and apprehension over the custody of their delicate genetic information, 23andMe asserted that any potential buyer must abide by its consumer privacy policies, per SFGATE.
